Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diffusion-weighted MRI for assessment of early cancer treatment response.
Galbán S, Brisset JC, Rehemtulla A, Chenevert TL, Ross BD, Galbán CJ. Galbán S, et al. Among authors: galban cj. Curr Pharm Biotechnol. 2010 Sep 1;11(6):701-8. doi: 10.2174/138920110792246627. Curr Pharm Biotechnol. 2010. PMID: 20504274 Free PMC article. Review.
Applications of molecular imaging.
Galbán CJ, Galbán S, Van Dort ME, Luker GD, Bhojani MS, Rehemtulla A, Ross BD. Galbán CJ, et al. Among authors: galban s. Prog Mol Biol Transl Sci. 2010;95:237-98. doi: 10.1016/B978-0-12-385071-3.00009-5. Prog Mol Biol Transl Sci. 2010. PMID: 21075334 Free PMC article. Review.
Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment.
Galbán CJ, Chenevert TL, Meyer CR, Tsien C, Lawrence TS, Hamstra DA, Junck L, Sundgren PC, Johnson TD, Galbán S, Sebolt-Leopold JS, Rehemtulla A, Ross BD. Galbán CJ, et al. Among authors: galban s. Clin Cancer Res. 2011 Jul 15;17(14):4751-60. doi: 10.1158/1078-0432.CCR-10-2098. Epub 2011 Apr 28. Clin Cancer Res. 2011. PMID: 21527563 Free PMC article. Clinical Trial.
DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma.
Galbán S, Lemasson B, Williams TM, Li F, Heist KA, Johnson TD, Leopold JS, Chenevert TL, Lawrence TS, Rehemtulla A, Mikkelsen T, Holland EC, Galbán CJ, Ross BD. Galbán S, et al. Among authors: galban cj. PLoS One. 2012;7(4):e35857. doi: 10.1371/journal.pone.0035857. Epub 2012 Apr 20. PLoS One. 2012. PMID: 22536446 Free PMC article.
148 results